Chemoinformaics analysis of 2,2-Diethyl-N-ethylpyrrolidine
Molecular Weight | 155.285 | nRot | 3 |
Heavy Atom Molecular Weight | 134.117 | nRig | 5 |
Exact Molecular Weight | 155.167 | nRing | 1 |
Solubility: LogS | -2.356 | nHRing | 1 |
Solubility: LogP | 3.151 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 21 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 10 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 31.8027 |
nHD | 0 | BPOL | 22.7773 |
QED | 0.605 |
Synth | 3.065 |
Natural Product Likeliness | 0.188 |
NR-PPAR-gamma | 0.004 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.001 |
Pgp-sub | 0.148 |
HIA | 0.003 |
CACO-2 | -4.494 |
MDCK | 0.0000111 |
BBB | 0.98 |
PPB | 0.422579 |
VDSS | 2.082 |
FU | 0.665855 |
CYP1A2-inh | 0.055 |
CYP1A2-sub | 0.921 |
CYP2c19-inh | 0.047 |
CYP2c19-sub | 0.954 |
CYP2c9-inh | 0.005 |
CYP2c9-sub | 0.244 |
CYP2d6-inh | 0.796 |
CYP2d6-sub | 0.895 |
CYP3a4-inh | 0.011 |
CYP3a4-sub | 0.368 |
CL | 11.16 |
T12 | 0.308 |
hERG | 0.042 |
Ames | 0.026 |
ROA | 0.889 |
SkinSen | 0.622 |
Carcinogencity | 0.935 |
EI | 0.789 |
Respiratory | 0.986 |
NR-Aromatase | 0.005 |
Antiviral | No |
Prediction | 0.898617 |